USP22 and cancer: Interestingly, the Ubp8 homolog USP22 has been identified as a member of an 11-gene “death from cancer” signature that acts as a predictor of tumor aggressiveness, treatment resistance, and metastatic probability in cancer patients (Atanassov and Dent 2011; Glinsky 2006; Liu et al. 2010).